Results for 'Testing'
Find oncology podcasts about Testing — interviews, panel discussions, and expert-led audio on cancer innovation. Open any episode for listening options and show notes; switch tabs to explore articles, partners, and community members.
Jesus Izaguirre-Carbonell
Enhancing Cancer Treatment Decisions with Ultrasensitive MRD Testing
Quest, Diagnostics, MRD, minimal residual testing, precision, biomarker
Dr. Thomas Slavin breaks down how ultrasensitive MRD testing supports better cancer treatment decisions and enables earlier, more personalized interventions.
Jul 7th • 19 mins listen
Rebecca Previs
Why Genetic Testing Should Be Standard in Prostate Cancer
diagnostic, genetic counselor, genetic testing, prostate cancer, urologic oncology, digital
Hear why universal genetic testing matters in prostate cancer — plus, how it can improve treatment, equity, and outcomes for patients everywhere.
May 18th • 19 mins listen
Rebecca Previs
Empowering Breast Cancer Patients: Biomarker Breakthroughs & Self-Advocacy
diagnostic, breast cancer, digital, biomarker, genetic testing, advocacy
Suzanne Garner’s journey shows how education, advocacy, and technology are reshaping breast cancer patient care and clinical trial access.
Oct 19th • 26 mins listen
Rebecca Previs
Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story
diagnostic, biomarker, lung cancer, advocacy, precision
Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.
Jul 31st • 23 mins listen
Rebecca Previs
FFPE: The Workhorse Behind NGS Testing
biomarker, sequencing, diagnostics, translational research, precision
Exploring FFPE’s impact on precision oncology, NGS innovation, and the future of tissue stewardship in cancer care with leading Labcorp experts.
Jan 28th • 33 mins listen
The Oncology Nursing Podcast
Nurse Innovators Increase Access to Biomarker Testing During ONS Hackathon
ONS members Meghan Coleman, DNP, CRNP, and Alison McDaniel, BSN, RN, OCN®, join Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss their Evidence-Based Quality Understanding in Pathology (EQUIP) project to solve unequal access to germline and s…
Dec 24th • 46 mins listen
The Oncology Nursing Podcast
Biomarker Testing Improves Outcomes for Patients With Non-Small Cell Lung Cancer
ONS member Beth Sandy, MSN, CRNP, thoracic oncology nurse practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss key considerations for oncology nurses regarding biomarker testing for …
May 24th • 34 mins listen
The Oncology Nursing Podcast
How Biomarker Testing Drives the Use of Targeted Therapies
ONS member Cyndy Simonson, MS, APRN-BC, AOCN®, oncology nurse practitioner who is the nursing editor at Duke Regional Hospital in Durham, NC, and member of the North Carolina Triangle ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss biomarker testi…
Aug 24th • 40 mins listen
The Oncology Nursing Podcast
Learn How Nurse Practitioners Use Biomarker Testing in Cancer Care
ONS members Kristin Daly, MSN, ANP-BC, AOCNP®, medical oncology nurse practitioner at the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, MO, and Jessica Pforr, RN, AOCNP®, nurse practitioner at Mon Medical Center in Morgantown, WV, join Stephanie Jardine,…
Mar 29th • 38 mins listen
Dr. Rebecca Previs
Advancing Endometrial Cancer Care with Molecular Profiling
endometrial cancer care, prognosis, precision treatment
How molecular profiling of GOG258 is changing advanced endometrial cancer care—insights on POL-E, prognosis, and precision treatment.
May 14th • 32 mins listen
The Pulse of the Oncologist: Listening to What Matters Most
diagnostic, digital, molecular residual disease, MRD
Pulse of the Oncologist survey reveals trends in cancer diagnostics, digital solutions, care barriers, and the innovations transforming oncology today.
Apr 14th • 22 mins listen
Monty Pal
Unlocking the Future of Cancer Care: Precision Medicine, AI and the Patient Voice with Dr. Stacy Gray
City of Hope, Academic Research, precision medicine, AI
In this episode of On the Edge of Breakthrough: Voices of Cancer Research, Stacy Gray, M.D., A.M., Director of Clinical and Scientific Strategy and Vice President of System Strategy at City of Hope, joins Monty Pal, M.D., F.A.S.C.O. in an engaging discussion of how precision medicine and AI are tran…
Feb 23rd • 43 mins listen
Rebecca Previs
Tumor-Agnostic Therapies and the Future of HER2 in Oncology
diagnostic, precision oncology, tumor agnostic, breast cancer, gastric cancer, biomarker
What tumor-agnostic approvals mean for HER2, NGS, and precision oncology — and how they’re changing treatment across cancer types.
Jun 8th • 20 mins listen
Rebecca Previs
Rethinking How We Track and Treat Cancer
diagnostic, genomics, breast cancer, antibody drug conjugate, ADC, breast cancer, lung cancer, biomarker
HER2, HER3, and MRD: Drs. Previs and Green break down ASCO highlights and what they mean for the future of cancer diagnostics.
Jul 13th • 19 mins listen
Rebecca Previs
Redefining Ovarian Cancer Care with Biomarkers
diagnostic, ovarian cancer, biomarker, tumor biology
Exploring ovarian cancer, biomarkers HRD & RB1, and how Labcorp innovations are advancing precision oncology.
Sep 7th • 14 mins listen
The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…
Mar 30th • 47 mins listen
The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
CDER, FDA, Nurses, biomarker, immunomodulatory
Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…
Mar 30th • 53 mins listen